مصطلحات الفهرس: dose response, early diagnosis, fever/si [Side Effect], fibrosing alveolitis/di [Diagnosis], fibrosing alveolitis/dt [Drug Therapy], hematuria/si [Side Effect], hemorrhagic cystitis/si [Side Effect], high resolution computer tomography, human, pneumonia/si [Side Effect], infection/si [Side Effect], infertility/si [Side Effect], kidney disease/co [Complication], kidney disease/si [Side Effect], leukopenia/si [Side Effect], lung biopsy, lung function test, lung lavage, lung scintiscanning, maximum permissible dose, myelodysplasia/si [Side Effect], nausea/si [Side Effect], nephrotoxicity/si [Side Effect], osteoporosis/co [Complication], pathology, patient monitoring, pneumocystosis/dt [Drug Therapy], pneumocystosis/et [Etiology], pneumocystosis/pc [Prevention], thorax radiography, vomiting/si [Side Effect], autoantibody/ec [Endogenous Compound], azathioprine/ae [Adverse Drug Reaction], azathioprine/ct [Clinical Trial], azathioprine/cb [Drug Combination], azathioprine/cm [Drug Comparison], azathioprine/dt [Drug Therapy], azathioprine/iv [Intravenous Drug Administration], cotrimoxazole/dt [Drug Therapy], cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/ct [Clinical Trial], cyclophosphamide/ad [Drug Administration], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], cyclophosphamide/po [Oral Drug Administration], interleukin 8/ec [Endogenous Compound], mesna/ae [Adverse Drug Reaction], mesna/cb [Drug Combination], mesna/dt [Drug Therapy], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/iv [Intravenous Drug Administration], penicillamine/ae [Adverse Drug Reaction], penicillamine/ad [Drug Administration], penicillamine/cb [Drug Combination], penicillamine/dt [Drug Therapy], penicillamine/iv [Intravenous Drug Administration], penicillamine/po [Oral Drug Administration], pentetate technetium tc 99m, placebo, prednisolone/ae [Adverse Drug Reaction], prednisolone/ct [Clinical Trial], prednisolone/cb [Drug Combination], prednisolone/cm [Drug Comparison], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], tumor necrosis factor alpha/ec [Endogenous Compound], unclassified drug, dna topoisomerase antibody/ec [Endogenous Compound], scl 70 antibody/ec [Endogenous Compound], immunosuppressive treatment, priority journal, review, screening, systemic sclerosis/dt [Drug Therapy], algorithm, alopecia/si [Side Effect], bladder cancer/si [Side Effect], bladder disease/si [Side Effect], blood toxicity/si [Side Effect], bone marrow suppression/si [Side Effect], cause of death, clinical feature, clinical trial, cytopenia/si [Side Effect], disease marker, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32494Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: hypokalemia/si [Side Effect], hypomagnesemia/si [Side Effect], hyponatremia/si [Side Effect], hypophosphatemia/si [Side Effect], infant, leukopenia/si [Side Effect], male, metastasis/co [Complication], multiple cycle treatment, overall survival, patient safety, priority journal, radiation field, second look surgery, stem cell transplantation, systemic therapy, thrombocytopenia/si [Side Effect], treatment outcome, treatment response, carboplatin/ae [Adverse Drug Reaction], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], cisplatin/cb [Drug Combination], cisplatin/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], etoposide/cb [Drug Combination], etoposide/do [Drug Dose], etoposide/dt [Drug Therapy], etoposide/po [Oral Drug Administration], melphalan/ae [Adverse Drug Reaction], melphalan/cb [Drug Combination], melphalan/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/do [Drug Dose], vincristine/dt [Drug Therapy], prognosis, anemia/si [Side Effect], article, bone marrow toxicity/si [Side Effect], cancer chemotherapy, cancer patient, central nervous system tumor/dt [Drug Therapy], central nervous system tumor/rt [Radiotherapy], central nervous system tumor/su [Surgery], child, childhood cancer/dt [Drug Therapy], childhood cancer/rt [Radiotherapy], childhood cancer/su [Surgery], clinical article, drug megadose, event free survival, febrile neutropenia/si [Side Effect], female, human, hypocalcemia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30328Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: hemoglobinuria/dt [Drug Therapy], hemolytic anemia/co [Complication], hemolytic anemia/th [Therapy], human, intravascular hemolysis, lactate dehydrogenase blood level, letter, male, multiple myeloma/dt [Drug Therapy], priority journal, rosette formation, single drug dose, treatment duration, urine level, bilirubin/ec [Endogenous Compound], bortezomib/cb [Drug Combination], bortezomib/dt [Drug Therapy], complement component C3/ec [Endogenous Compound], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], dexamethasone/cb [Drug Combination], dexamethasone/dt [Drug Therapy], eculizumab/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], hemosiderin/ec [Endogenous Compound], lactate dehydrogenase/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], thalidomide/cb [Drug Combination], thalidomide/dt [Drug Therapy], cold hemoglobinuria/co [Complication], cold hemoglobinuria/di [Diagnosis], cold hemoglobinuria/dr [Drug Resistance], cold hemoglobinuria/dt [Drug Therapy], hemoglobinuria/di [Diagnosis], adult, bilirubin blood level, cancer staging, case report, diagnostic test, disease severity, drug megadose, drug treatment failure, erythrocyte transfusion, erythrophagocytosis, hemoglobin blood level, hemoglobinuria/co [Complication], hemoglobinuria/dr [Drug Resistance], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30374Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: female infertility/di [Diagnosis], immunosuppressive treatment, major clinical study, male, male infertility/di [Diagnosis], male infertility/si [Side Effect], male infertility/th [Therapy], oligospermia/di [Diagnosis], oligospermia/si [Side Effect], ovary insufficiency/si [Side Effect], patient counseling, priority journal, reproduction, semen analysis, spermatozoon count, survival time, androgen/ec [Endogenous Compound], busulfan/ae [Adverse Drug Reaction], busulfan/cb [Drug Combination], busulfan/do [Drug Dose], busulfan/dt [Drug Therapy], carmustine/ae [Adverse Drug Reaction], carmustine/cb [Drug Combination], carmustine/dt [Drug Therapy], chlorambucil, cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], estradiol/ec [Endogenous Compound], etoposide/ae [Adverse Drug Reaction], etoposide/cb [Drug Combination], etoposide/do [Drug Dose], etoposide/dt [Drug Therapy], follitropin/ec [Endogenous Compound], inhibin B/ec [Endogenous Compound], luteinizing hormone/ec [Endogenous Compound], melphalan/ae [Adverse Drug Reaction], melphalan/cb [Drug Combination], melphalan/dt [Drug Therapy], testosterone/ec [Endogenous Compound], adolescent, adult, amenorrhea/si [Side Effect], article, bone marrow transplantation, chronic disease, controlled study, convalescence, dose response, female, female infertility/si [Side Effect], female infertility/th [Therapy], follow up, graft versus host reaction/co [Complication], graft versus host reaction/dt [Drug Therapy], health status, hormone blood level, hormone deficiency/si [Side Effect], hormone substitution, human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33370Test
Click here for full text options
LibKey Link

مصطلحات الفهرس: advanced cancer/th [Therapy], article, bone scintiscanning, breast cancer/dt [Drug Therapy], breast cancer/th [Therapy], breast metastasis/dt [Drug Therapy], breast metastasis/th [Therapy], cancer localization, cancer regression, cancer staging, cancer survival, clinical article, clinical trial, cohort analysis, controlled clinical trial, controlled study, cytapheresis, diarrhea/si [Side Effect], dose response, hematopoietic stem cell transplantation, human, interstitial pneumonia/si [Side Effect], mucosa inflammation/si [Side Effect], peripheral blood stem cell, phase 1 clinical trial, positron emission tomography, priority journal, rash/si [Side Effect], cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/ct [Clinical Trial], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], docetaxel/ae [Adverse Drug Reaction], docetaxel/ct [Clinical Trial], docetaxel/do [Drug Dose], docetaxel/dt [Drug Therapy], mesna/do [Drug Dose], mesna/dt [Drug Therapy], recombinant granulocyte colony stimulating factor/ct [Clinical Trial], recombinant granulocyte colony stimulating factor/sc [Subcutaneous Drug Administration], thiotepa/ae [Adverse Drug Reaction], thiotepa/ct [Clinical Trial], thiotepa/do [Drug Dose], thiotepa/dt [Drug Therapy], follow up, adult, advanced cancer/dt [Drug Therapy], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33380Test
LibKey Link

مصطلحات الفهرس: dose response, early diagnosis, fever/si [Side Effect], fibrosing alveolitis/di [Diagnosis], fibrosing alveolitis/dt [Drug Therapy], hematuria/si [Side Effect], hemorrhagic cystitis/si [Side Effect], high resolution computer tomography, human, pneumonia/si [Side Effect], infection/si [Side Effect], infertility/si [Side Effect], kidney disease/co [Complication], kidney disease/si [Side Effect], leukopenia/si [Side Effect], lung biopsy, lung function test, lung lavage, lung scintiscanning, maximum permissible dose, myelodysplasia/si [Side Effect], nausea/si [Side Effect], nephrotoxicity/si [Side Effect], osteoporosis/co [Complication], pathology, patient monitoring, pneumocystosis/dt [Drug Therapy], pneumocystosis/et [Etiology], pneumocystosis/pc [Prevention], thorax radiography, vomiting/si [Side Effect], autoantibody/ec [Endogenous Compound], azathioprine/ae [Adverse Drug Reaction], azathioprine/ct [Clinical Trial], azathioprine/cb [Drug Combination], azathioprine/cm [Drug Comparison], azathioprine/dt [Drug Therapy], azathioprine/iv [Intravenous Drug Administration], cotrimoxazole/dt [Drug Therapy], cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/ct [Clinical Trial], cyclophosphamide/ad [Drug Administration], cyclophosphamide/cb [Drug Combination], cyclophosphamide/cm [Drug Comparison], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], cyclophosphamide/po [Oral Drug Administration], interleukin 8/ec [Endogenous Compound], mesna/ae [Adverse Drug Reaction], mesna/cb [Drug Combination], mesna/dt [Drug Therapy], methotrexate/ae [Adverse Drug Reaction], methotrexate/cb [Drug Combination], methotrexate/dt [Drug Therapy], methotrexate/iv [Intravenous Drug Administration], penicillamine/ae [Adverse Drug Reaction], penicillamine/ad [Drug Administration], penicillamine/cb [Drug Combination], penicillamine/dt [Drug Therapy], penicillamine/iv [Intravenous Drug Administration], penicillamine/po [Oral Drug Administration], pentetate technetium tc 99m, placebo, prednisolone/ae [Adverse Drug Reaction], prednisolone/ct [Clinical Trial], prednisolone/cb [Drug Combination], prednisolone/cm [Drug Comparison], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], tumor necrosis factor alpha/ec [Endogenous Compound], unclassified drug, dna topoisomerase antibody/ec [Endogenous Compound], scl 70 antibody/ec [Endogenous Compound], immunosuppressive treatment, priority journal, review, screening, systemic sclerosis/dt [Drug Therapy], algorithm, alopecia/si [Side Effect], bladder cancer/si [Side Effect], bladder disease/si [Side Effect], blood toxicity/si [Side Effect], bone marrow suppression/si [Side Effect], cause of death, clinical feature, clinical trial, cytopenia/si [Side Effect], disease marker, Review

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32494Test
LibKey Link

مصطلحات الفهرس: hypokalemia/si [Side Effect], hypomagnesemia/si [Side Effect], hyponatremia/si [Side Effect], hypophosphatemia/si [Side Effect], infant, leukopenia/si [Side Effect], male, metastasis/co [Complication], multiple cycle treatment, overall survival, patient safety, priority journal, radiation field, second look surgery, stem cell transplantation, systemic therapy, thrombocytopenia/si [Side Effect], treatment outcome, treatment response, carboplatin/ae [Adverse Drug Reaction], carboplatin/cb [Drug Combination], carboplatin/dt [Drug Therapy], cisplatin/cb [Drug Combination], cisplatin/dt [Drug Therapy], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], etoposide/cb [Drug Combination], etoposide/do [Drug Dose], etoposide/dt [Drug Therapy], etoposide/po [Oral Drug Administration], melphalan/ae [Adverse Drug Reaction], melphalan/cb [Drug Combination], melphalan/dt [Drug Therapy], vincristine/cb [Drug Combination], vincristine/do [Drug Dose], vincristine/dt [Drug Therapy], prognosis, anemia/si [Side Effect], article, bone marrow toxicity/si [Side Effect], cancer chemotherapy, cancer patient, central nervous system tumor/dt [Drug Therapy], central nervous system tumor/rt [Radiotherapy], central nervous system tumor/su [Surgery], child, childhood cancer/dt [Drug Therapy], childhood cancer/rt [Radiotherapy], childhood cancer/su [Surgery], clinical article, drug megadose, event free survival, febrile neutropenia/si [Side Effect], female, human, hypocalcemia/si [Side Effect], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30328Test
LibKey Link

مصطلحات الفهرس: hemoglobinuria/dt [Drug Therapy], hemolytic anemia/co [Complication], hemolytic anemia/th [Therapy], human, intravascular hemolysis, lactate dehydrogenase blood level, letter, male, multiple myeloma/dt [Drug Therapy], priority journal, rosette formation, single drug dose, treatment duration, urine level, bilirubin/ec [Endogenous Compound], bortezomib/cb [Drug Combination], bortezomib/dt [Drug Therapy], complement component C3/ec [Endogenous Compound], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cyclophosphamide/iv [Intravenous Drug Administration], dexamethasone/cb [Drug Combination], dexamethasone/dt [Drug Therapy], eculizumab/dt [Drug Therapy], hemoglobin/ec [Endogenous Compound], hemosiderin/ec [Endogenous Compound], lactate dehydrogenase/ec [Endogenous Compound], prednisolone/cb [Drug Combination], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], thalidomide/cb [Drug Combination], thalidomide/dt [Drug Therapy], cold hemoglobinuria/co [Complication], cold hemoglobinuria/di [Diagnosis], cold hemoglobinuria/dr [Drug Resistance], cold hemoglobinuria/dt [Drug Therapy], hemoglobinuria/di [Diagnosis], adult, bilirubin blood level, cancer staging, case report, diagnostic test, disease severity, drug megadose, drug treatment failure, erythrocyte transfusion, erythrophagocytosis, hemoglobin blood level, hemoglobinuria/co [Complication], hemoglobinuria/dr [Drug Resistance], Letter

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/30374Test
LibKey Link

مصطلحات الفهرس: female infertility/di [Diagnosis], immunosuppressive treatment, major clinical study, male, male infertility/di [Diagnosis], male infertility/si [Side Effect], male infertility/th [Therapy], oligospermia/di [Diagnosis], oligospermia/si [Side Effect], ovary insufficiency/si [Side Effect], patient counseling, priority journal, reproduction, semen analysis, spermatozoon count, survival time, androgen/ec [Endogenous Compound], busulfan/ae [Adverse Drug Reaction], busulfan/cb [Drug Combination], busulfan/do [Drug Dose], busulfan/dt [Drug Therapy], carmustine/ae [Adverse Drug Reaction], carmustine/cb [Drug Combination], carmustine/dt [Drug Therapy], chlorambucil, cyclophosphamide/ae [Adverse Drug Reaction], cyclophosphamide/cb [Drug Combination], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], cytarabine/ae [Adverse Drug Reaction], cytarabine/cb [Drug Combination], cytarabine/dt [Drug Therapy], estradiol/ec [Endogenous Compound], etoposide/ae [Adverse Drug Reaction], etoposide/cb [Drug Combination], etoposide/do [Drug Dose], etoposide/dt [Drug Therapy], follitropin/ec [Endogenous Compound], inhibin B/ec [Endogenous Compound], luteinizing hormone/ec [Endogenous Compound], melphalan/ae [Adverse Drug Reaction], melphalan/cb [Drug Combination], melphalan/dt [Drug Therapy], testosterone/ec [Endogenous Compound], adolescent, adult, amenorrhea/si [Side Effect], article, bone marrow transplantation, chronic disease, controlled study, convalescence, dose response, female, female infertility/si [Side Effect], female infertility/th [Therapy], follow up, graft versus host reaction/co [Complication], graft versus host reaction/dt [Drug Therapy], health status, hormone blood level, hormone deficiency/si [Side Effect], hormone substitution, human, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/33370Test
LibKey Link

مصطلحات الفهرس: antineoplastic agent/dt [Drug Therapy], CD34 antigen/ec [Endogenous Compound], ciprofloxacin/dt [Drug Therapy], cyclophosphamide/do [Drug Dose], cyclophosphamide/dt [Drug Therapy], docetaxel/do [Drug Dose], docetaxel/dt [Drug Therapy], mesna/do [Drug Dose], mesna/dt [Drug Therapy], paclitaxel/do [Drug Dose], paclitaxel/dt [Drug Therapy], ranitidine/dt [Drug Therapy], recombinant granulocyte colony stimulating factor/do [Drug Dose], recombinant granulocyte colony stimulating factor/sc [Subcutaneous Drug Administration], thiotepa/do [Drug Dose], thiotepa/dt [Drug Therapy], recombinant granulocyte colony stimulating factor/dt [Drug Therapy], adult, article, autotransplantation, breast cancer/dt [Drug Therapy], breast cancer/su [Surgery], cancer resistance, clinical article, controlled study, correlation analysis, cryopreservation, dose response, drug megadose, hematopoietic stem cell transplantation, human, infection/co [Complication], infection/dt [Drug Therapy], infection/pc [Prevention], leukocyte count, neutropenia, peripheral blood stem cell, thrombocytopenia, toxicity/si [Side Effect], aciclovir/dt [Drug Therapy], antineoplastic agent/ae [Adverse Drug Reaction], antineoplastic agent/do [Drug Dose], Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/32853Test
Click here for full text options
LibKey Link